Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Considering the promising results of the SURPASS and SURMOUNT trials, what additional factors or challenges must researchers address before adopting tirzepatide for conditions beyond Type 2 diabetes, such as non-alcoholic fatty liver disease (NAFLD)
Communicating the benefits of CGMS, such as detecting blood glucose fluctuations throughout the day and night, helps patients understand the value of this technology in optimizing their diabetes management
doi: 10.1016/j.atherosclerosis.2011.09.038
This is useful for calculating precise doses, especially when working with smaller amounts
US$ 20.35
US$ 22.06
US$ 20.82
US$ 23.24
US$ 22.19
